Spectral Medical Inc. (TSE:EDT – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday . The stock traded as high as C$0.85 and last traded at C$0.84, with a volume of 196600 shares trading hands. The stock had previously closed at C$0.78.
Spectral Medical Price Performance
The firm has a market capitalization of C$230.63 million, a price-to-earnings ratio of -11.71 and a beta of 0.96. The company has a current ratio of 0.61, a quick ratio of 0.45 and a debt-to-equity ratio of 26.03. The business has a 50-day moving average price of C$0.70 and a two-hundred day moving average price of C$0.60.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Read More
- Five stocks we like better than Spectral Medical
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Best Stocks Under $10.00
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- What is the Dogs of the Dow Strategy? Overview and Examples
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
